peptide elongation factor 2 has been researched along with 5-hydroxythalidomide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, H; Matsunaga, N; Nakamura, S; Obata, T; Sasaki, T; Shibata, N; Sukeguchi, D; Takashima, M; Tanaka, M; Toru, T; Yamamoto, T | 1 |
1 other study(ies) available for peptide elongation factor 2 and 5-hydroxythalidomide
| Article | Year |
|---|---|
Synthesis, configurational stability and stereochemical biological evaluations of (S)- and (R)-5-hydroxythalidomides.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Cell Line; Drug Screening Assays, Antitumor; Humans; Hydrogen-Ion Concentration; Stereoisomerism; Thalidomide | 2009 |